Related Experiment Videos
The structural basis of phenylketonuria
1Department of Molecular Biology and Institute for Childhood and Neglected Diseases, The Scripps Research Institute, La Jolla, California, 92037, USA.
Molecular Genetics and Metabolism
|October 21, 1999
Summary
Phenylketonuria (PKU) is caused by mutations in the phenylalanine hydroxylase gene (PAH). Understanding PAH gene mutations and cofactor tetrahydrobiopterin is key to PKU research.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- The phenylalanine hydroxylase gene (PAH) encodes the hepatic enzyme phenylalanine hydroxylase (PheOH).
- PheOH is crucial for metabolizing the essential amino acid l-phenylalanine into tyrosine, representing 75% of phenylalanine disposal.
- Mutations in PAH cause phenylketonuria (PKU), an autosomal recessive disorder, with 99% of mutations occurring in the PAH gene.
Purpose of the Study:
- To elucidate the structural basis of phenylalanine hydroxylase (PheOH) mutations.
- To understand the role of cofactor tetrahydrobiopterin in PheOH enzymatic activity.
- To provide a structural framework for future research into PKU mutations.
Main Methods:
- Analysis of the human phenylalanine hydroxylase gene (PAH) and its encoded enzyme PheOH.
- Investigation of mutations within the PAH gene associated with hyperphenylalaninemia and PKU.
- Utilizing recently solved crystal structures of human phenylalanine hydroxylase.
Main Results:
- Identified that 99% of PKU-causing mutations are in the PAH gene.
- Highlighted that 1% of mutations involve genes for tetrahydrobiopterin biosynthesis or regeneration.
- Established crystal structures of human PheOH offer a scaffold for understanding mutation effects.
Conclusions:
- The PAH gene is the primary determinant of PKU.
- Cofactor tetrahydrobiopterin pathway defects also contribute to PKU.
- Structural insights into PheOH aid in understanding PKU pathogenesis and guide future studies.